Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3708650014 | Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3708651013 | Atropine- and hyoscyamine- and scopolamine-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3708652018 | Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Has active ingredient | Scopolamine (substance) | true | Inferred relationship | Some | 3 | |
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Is a | Product containing atropine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Has active ingredient | Atropine (substance) | true | Inferred relationship | Some | 2 | |
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Is a | Product containing hyoscyamine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Has active ingredient | Hyoscyamine (substance) | true | Inferred relationship | Some | 1 | |
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Is a | Product containing atropine and hyoscyamine and scopolamine (medicinal product) | true | Inferred relationship | Some | ||
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Is a | Hyoscine-containing product in oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) | Is a | False | Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Inferred relationship | Some | |
Atropine and hyoscine and hyoscyamine only product in oral dose form | Is a | True | Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | Inferred relationship | Some |
Reference Sets